Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|January 4, 2017
Screening Immunomodulators To Skew the Antigen-Specific Autoimmune ResponseLaura Northrup, Bradley P Sullivan, Brittany L Hartwell, et al.
Journal of Pharmaceutical Sciences|December 3, 2014
Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapiesBrittany L Hartwell, Lorena Antunez, Bradley P Sullivan, et al.
Frontiers in Immunology|September 17, 2024
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptakeMadison L Seefeld, Erin L Templeton, Justin M Lehtinen, et al.
Biomacromolecules|January 16, 2016
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated SignalingBrittany L Hartwell, Francisco J Martinez-Becerra, Jun Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2017
Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitisLaura Northrup, J Daniel Griffin, Matthew A Christopher, et al.
Journal of Autoimmunity|July 16, 2018
Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitisBrittany L Hartwell, Chad J Pickens, Martin Leon, et al.
The AAPS Journal|October 10, 2014
Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitisLaura Northrup, Joshua O Sestak, Bradley P Sullivan, et al.
Biomacromolecules|April 19, 2019
Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in SplenocytesJ Daniel Griffin, Martin A Leon, Jean R Salash, et al.
Pageof 2